| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 716678 | Null | 0.00182957917645007 | 0.036280169 |
| NSC 716688 | Null | 0.00182957917645007 | -0.32720641 |
| NSC 722985 | Null | 0.00182957917645007 | 0.31634139 |
| NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.00182957917645007 | 0.54754545 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.00216534295403404 | 0.27698826 |
| NSC 13151 | Null | 0.00216534295403404 | 0.44390926 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.00216534295403404 | 0.30191661 |
| NSC 185065 | Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- | 0.00216534295403404 | 0.1767634 |
| NSC 371777 | Null | 0.00216534295403404 | 0.17801767 |
| NSC 685827 | Null | 0.00216534295403404 | 0.24899833 |